Hyponatremia and Congestive Heart Failure: A Marker of Increased Mortality and a Target for Therapy
Open Access
- 1 January 2011
- journal article
- Published by Hindawi Limited in International Journal of Nephrology
- Vol. 2011, 1-7
- https://doi.org/10.4061/2011/732746
Abstract
Heart failure is one of the most common chronic medical conditions in the developed world. It is characterized by neurohormonal activation of multiple systems that can lead to clinical deterioration and significant morbidity and mortality. In this regard, hyponatremia is due to inappropriate and continued vasopressin activity despite hypoosmolality and volume overload. Hyponatremia is also due to diuretic use in an attempt to manage volume overload. When hyponatremia occurs, it is a marker of heart failure severity and identifies patients with increased mortality. The recent introduction of specific vasopressin-receptor antagonists offers a targeted pharmacological approach to these pathophysiological derangements. Thus far, clinical trials with vasopressin-receptor antagonists have demonstrated an increase in free-water excretion, improvement in serum sodium, modest improvements in dyspnea but no improvement in mortality. Continued clinical trials with these agents are needed to determine their specific role in the treatment of both chronic and decompensated heart failure.Keywords
This publication has 49 references indexed in Scilit:
- Chronic Heart Failure: Contemporary Diagnosis and ManagementMayo Clinic Proceedings, 2010
- Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE TrialEuropean Journal of Heart Failure, 2007
- Review of Current and Investigational Pharmacologic Agents for Acute Heart Failure SyndromesThe American Journal of Cardiology, 2007
- Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methodsEuropean Heart Journal, 2006
- Hyponatremia in Patients with Heart FailureThe American Journal of Cardiology, 2005
- Vasopressin: a new target for the treatment of heart failureAmerican Heart Journal, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Diuretic Combinations in Refractory Oedema StatesClinical Pharmacokinetics, 1996
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Arginine vasopressin and the renal response to water loading in congestive heart failureThe American Journal of Cardiology, 1986